STK11 and neoplasm: Application of this model to over 11,000 tumor genomes across ~30 cancer types revealed that chemotherapeutic exposure can induce treatment-associated selection in genes including PIK3CA, APC, MAP2K4, SMAD4, STK11, and MAP3K1, each of which contributes to critical signaling networks governing tumor survival, EMT, and immune evasion.